Back to Agenda
Session 2: Globalisation Of PSMF : Practical Implementation
Session Chair(s)
Francoise Sillan, MD
EU1 UK QPPV
Ipsen, France
Willemijn van der Spuij, MSc
Executive Director, WorldWide Patient Safety International, Europe
Switzerland
This session focusses on the PSMF requirements from a global perspective. With the expansion of PSMF, or similar, requirements, better understanding the landscape in which we operate will be beneficial to participants. Through the lens of various experts we will be looking at how varying global requirements impact the concept of the PV system and its description, its development and maintenance. The session will cover a deep dive into some of the PSMF requirements outside the EEA. We will explore the learnings to be taken from audit findings by looking at what trends have been observed and can be used as part of the global consideration and improvements. And the session will include a regulators view, what are the requirements and expectations specific to the UK for the PSMF. Why are these requirements so important.
The Q&A as part of this session will allow the participants to interact with the experts and discuss considerations for pragmatic ways of working for the PSMF in the global environment.
Speaker(s)
Global Perspective on The Implementation of the PSMF
Sean Burke, MSc
Merck , United Kingdom
(EFPIA IPVG Representative) Pharmacovigilance Lead, EEMEA
National Authority (outside EU)
Aalaa Afdal Mogheith, MPA, MPharm
Egyptian Drug Authority (EDA), Egypt
Head of Pharmaceutical Vigilance, General Administrator
Audit Perspective on the PSMF
Melanie Weber Weber, MSc
Pietrek Associates Gmbh, Germany
Pharmacovigilance Expert
MHRA Perspective
Claire Longman, MSc
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Expert Pharmacovigilance Inspector
Have an account?